Company: AZN
Filing Date: 2025-03-06
Form Type: 6-K
Source: 0001654954-25-002350
Chunk: 1

Company: ASTRAZENECA PLC
Filing Date: 2025-03-06
Form: 6-K
Chunk 1
---
 
                     auction platform, auctioneer or auction monitor |                                                                 |           |
| a) |                                                                Name | AstraZeneca PLC                                                 |           |
| b) |                                                                 LEI | PY6ZZQWO2IZFZC3IOL08                                            |           |
| 4  |  Details of the transaction(s): section to be repeated for (i) each 
 type of instrument; (ii) each type of transaction; (iii) each date; 
                    and (iv) each place where transactions have been 
                                                           conducted |                                                                 |           |
| a) |                    Description of the financial instrument, type of 
                                                          instrument 
                                                 Identification code | Ordinary Shares of US$0.25 each in AstraZeneca PLC              
 GB0009895292                                                    |           |
| b) |                                           Nature of the transaction | Acquisition of shares following the reinvestment of certain     
 dividends accrued during the deferral period of the AstraZeneca 
 Deferred Bonus Plan award.                                      |           |
| c) |                                              Price(s) and volume(s) | Price(s)                                                        | Volume(s) |
| 0  |                                                                  28 |                                                                 |           |
| d) |                                              Aggregated information 
                                                 - Aggregated volume 
                                                             - Price | Not applicable - single transaction                             |           |
| e) |                                             Date of the transaction | 5 March 2025                                                    |           |
| f) |                                            Place of the transaction | Outside a trading venue                                         |           |

#### AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca's innovative medicines are sold in more than 125 countries and used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on social media @AstraZeneca

#### Contacts
For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

#### Adrian Kemp

#### Company Secretary

#### AstraZeneca PLC
<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be